Cardiovascular Outcomes Update in SGLT-2 Inhibitors

January 14, 2021

Patients with diabetes, especially advanced diabetes, typically have comorbid cardiovascular disease. Current practice is to manage hyperglycemia via insulin, metformin, or selection of additional agents based on cost, patient preference, and side effect profiles. Furthermore, the cardiovascular disease is managed via the ACEi/ARBs, beta-blockers, calcium channel blockers and other cardiovascular agents. SGLT-2 inhibitor manufacturers recently published data to support the use of SGLT-2 inhibitors in cardiovascular disease with or without diabetes. This CE presentation will present new and existing data for the use of SGLT-2 inhibitors in cardiovascular disease. This will help pharmacy staff and health care professionals to make appropriate decisions for their patients regarding their chronic disease management.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Describe cardiovascular mechanisms of SGLT-2 inhibitors
  2. Review and discuss recent cardiovascular outcomes from SGLT-2 trials
  3. Outline placement of SGLT-2 inhibitors in treatment algorithms

Pharmacy technician learning objectives

  1. Recognize medications used in diabetes and heart failure
  2. Describe the role of SGLT-2 medications in diabetes and heart failure

Additional Information

AttachmentSize
PDF icon Helpful Tips for Users.pdf157.72 KB
File Information for CE Credit - Cardiovascular Outcomes Update in SGLT-2 Inhibitors.docx125.06 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE – Attendance
Course opens: 
01/14/2021
Course expires: 
02/28/2021
Event starts: 
01/14/2021 - 12:00pm CST
Event ends: 
01/14/2021 - 1:00pm CST
Add to calendar: 
ChristianaCare
Newark, DE
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
 
Planning committee members
Kesha Wright, PharmD
Clinical Pharmacist
ChristianaCare
 
Shannan Street, PharmD
PGY-1 Pharmacy Resident
ChristianaCare
 
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
 
Presenter
Shannan Street, PharmD
PGY-1 Pharmacy Resident
ChristianaCare
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-074-L01-P
Universal Activity Number: JA0006103-9999-21-074-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE – Attendance
Please login or register to take this course.